ArticleBMC infectious diseases2025
Norwegian scabies hid in advanced AIDS-associated talaromycosis misdiagnosed as atopic dermatitis: a case report.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCrusted scabies (Norwegian scabies), a rare variant of scabies infestation, typically manifests in immunocompromised hosts or institutionalized patients with characteristic hyperkeratosis and fissured plaques. In AIDS patients with concurrent opportunistic infections like talaromycosis, scabies diagnosis may be obscured by overlapping cutaneous manifestations, potentially delaying appropriate management. This case highlights the diagnostic challenges in differentiating crusted scabies from treatment-refractory dermatitis in advanced HIV patients. CASE PRESENTATION: A 46-year-old male with advanced AIDS (the absolute CD4 + count is 3 cells/ul) presented to the emergency department with persistent fever and progressive hyperkeratotic lesions. Two months prior, the patient had been misdiagnosed with atopic dermatitis and treated with dupilumab therapy. Subsequently, talaromycosis-associated febrile symptoms and lymphadenopathy had resolved following liposomal amphotericin B and antiretroviral therapy. Dermatological manifestations, however, remained refractory. Upon readmission, physical examination demonstrated coalescing gray-brown hyperkeratotic plaques with fissures and erythematous denuded areas distributed on the trunk, extremities, and thighs. Histopathologic analysis of biopsy identified Sarcoptes scabiei mites embedded in the stratum corneum, with microscopy of skin scrapings confirming motile mites. Treatment included topical sulfur ointment and oral ivermectin. Gradual resolution of crusts occurred over 4 weeks.
conclusionsThis case underscores the imperative for comprehensive dermatological evaluation in immunocompromised hosts with atypical cutaneous presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.